Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Selinexor

EU orphan designation number: EU/3/14/1354   
Active ingredient: Selinexor
Indication: Treatment of chronic lymphocytic leukaemia / small lymphocytic lymphoma
Sponsor: Karyopharm Europe GmbH
Franziska-Bilek-Weg 9, 80339 München, Deutschland

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2014 Orphan designation EMA/OD/078/14 (2014)8847 of 19/11/2014
14/08/2015 Transfer of orphan designation EMA/OD/078/14/T/01 (2015)5845 of 12/08/2015